✦ LIBER ✦

Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma

✍ Scribed by Ihor Pidhorecky; R. Jeffrey Lee; Gary Proulx; Daniel R. Kollmorgen; Chaoying Jia; Deborah L. Driscoll; William G. Kraybill; John F. Gibbs

Publisher: Springer
Year: 2001
Tongue: English
Weight: 62 KB
Volume: 8
Category: Article
ISSN: 1068-9265
DOI: 10.1007/s10434-001-0109-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient risk factors and surgical morbid

Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients

✍ Marshall M. Urist; William A. Maddox; Janet E. Kennedyy; Charles M. Balch 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

Risk factors for local recurrence after

Risk factors for local recurrence after breast-conserving surgery

✍ I. Fredriksson; G. Liljegren; M. Palm-Sjövall; L.-G. Arnesson; S. O. Emdin; T. F 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

Risk factors for local recurrence after

Risk factors for local recurrence after breast-conserving therapy

✍ E. Shin; Yuichi Takatsuka; Yasuhiko Okamura; Tetsuro Kobayashi; Isamu Nishisho; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 64 KB

Genetic risk factors for melanoma

✍ Kathrine Damm Meyle; Per Guldberg 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 486 KB

Radiotherapy for nodal recurrence after

Radiotherapy for nodal recurrence after chemoradiotherapy for esophageal carcinoma

✍ Atsunori Yorozu 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 262 KB

Risk factors for recurrence of autoimmun

Risk factors for recurrence of autoimmune hepatitis after liver transplantation

✍ Aldo J. Montano-Loza; Andrew L. Mason; Mang Ma; Ravin J. Bastiampillai; Vincent 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 1 views

Autoimmune hepatitis has been reported to recur after liver transplantation. The aim of our study was to evaluate the risk factors associated with recurrence of autoimmune hepatitis. Forty-six patients that underwent liver transplantation because of end-stage liver disease secondary to autoimmune he